Sunshine Biopharma Inc.
SBFMW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001402328
No open-market purchases or sales by Sunshine Biopharma Inc. insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $2.57K in total; no superinvestor holds it.
Other share classesSBFM
Q2 2023 vs. Q1 2023
How the institutions holding Sunshine Biopharma Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 3 | 5 | +2 |
| Shares | 26.5K | 129.3K | +102.7K (+387.2%) |
| Value | $13.3K | $53.3K | +$40.0K (+301.7%) |
New holders (2)
Institutions that held Sunshine Biopharma Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 83,132 | $31.4K | 0.00% |
| Citadel Advisors LLC | 31,148 | $15.0K | 0.00% |
Sold out (0)
Institutions that held Sunshine Biopharma Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
None.